BSE Live
Feb 11, 16:01Prev. Close
74.26
Open Price
74.00
Bid Price (Qty.)
76.80 (6)
Offer Price (Qty.)
78.20 (199)
NSE Live
Feb 11, 15:52Prev. Close
74.18
Open Price
74.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
78.14 (480)
| Cash Flow of Brooks Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 7.57 | 7.57 | 9.58 | 9.17 | 7.30 | |
| Net CashFlow From Operating Activities | 2.13 | 11.70 | 5.39 | -1.78 | 3.96 | |
| Net Cash Used In Investing Activities | -1.12 | -5.88 | -1.32 | -41.02 | -0.84 | |
| Net Cash Used From Financing Activities | -0.07 | 0.29 | 0.16 | 60.61 | -3.10 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.94 | 6.12 | 4.23 | 17.81 | 0.01 | |
| Cash And Cash Equivalents Begin of Year | 0.55 | 23.87 | 19.64 | 0.87 | 0.86 | |
| Cash And Cash Equivalents End Of Year | 1.49 | 29.99 | 23.87 | 18.68 | 0.87 |
10.02.2026
Brooks Labs Standalone December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
10.02.2026
Brooks Labs Standalone December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y